GAIBANI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 5.802
AS - Asia 5.678
EU - Europa 3.953
AF - Africa 377
SA - Sud America 340
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.172
Nazione #
US - Stati Uniti d'America 5.710
SG - Singapore 1.542
VN - Vietnam 1.518
CN - Cina 1.457
IT - Italia 860
GB - Regno Unito 783
SE - Svezia 546
DE - Germania 497
HK - Hong Kong 342
BR - Brasile 240
IN - India 237
FR - Francia 219
RU - Federazione Russa 204
NL - Olanda 151
KR - Corea 150
IE - Irlanda 145
UA - Ucraina 135
FI - Finlandia 119
ZA - Sudafrica 118
CI - Costa d'Avorio 110
JP - Giappone 102
CH - Svizzera 59
TG - Togo 49
ID - Indonesia 48
BG - Bulgaria 45
EE - Estonia 42
CA - Canada 41
JO - Giordania 41
PH - Filippine 41
AR - Argentina 40
NG - Nigeria 37
MX - Messico 29
PK - Pakistan 28
BD - Bangladesh 26
IQ - Iraq 26
BE - Belgio 23
AT - Austria 21
SC - Seychelles 21
TH - Thailandia 21
TW - Taiwan 20
PL - Polonia 18
RO - Romania 16
TR - Turchia 16
AU - Australia 14
CO - Colombia 14
ES - Italia 12
LT - Lituania 11
SA - Arabia Saudita 11
EC - Ecuador 9
IR - Iran 9
PE - Perù 9
HR - Croazia 8
MY - Malesia 8
PT - Portogallo 8
CL - Cile 7
PY - Paraguay 7
TN - Tunisia 7
VE - Venezuela 7
GR - Grecia 6
LB - Libano 6
AZ - Azerbaigian 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
HN - Honduras 4
NZ - Nuova Zelanda 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
IL - Israele 3
KZ - Kazakistan 3
LI - Liechtenstein 3
NI - Nicaragua 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
UY - Uruguay 3
ZW - Zimbabwe 3
AL - Albania 2
BH - Bahrain 2
DK - Danimarca 2
GT - Guatemala 2
KG - Kirghizistan 2
LY - Libia 2
NO - Norvegia 2
YT - Mayotte 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DJ - Gibuti 1
EU - Europa 1
GE - Georgia 1
Totale 16.147
Città #
Singapore 1.051
Ashburn 712
Southend 674
Fairfield 492
Chandler 425
Hong Kong 325
Ho Chi Minh City 322
Santa Clara 314
Hanoi 289
San Jose 285
Hefei 268
Woodbridge 247
Seattle 235
Dong Ket 212
Wilmington 211
Houston 207
Princeton 194
Cambridge 179
Beijing 169
Dublin 143
Ann Arbor 140
Boardman 126
Seoul 119
Abidjan 110
Bologna 109
Lauterbourg 96
Helsinki 95
New York 88
Council Bluffs 86
Los Angeles 86
Tokyo 85
Jacksonville 84
Nanjing 75
Padova 75
Westminster 63
Milan 53
Bern 50
Berlin 49
Bremen 49
Lomé 49
Dallas 48
Rome 48
Jinan 47
Sofia 45
Da Nang 42
Guangzhou 42
Amman 41
Buffalo 41
Redwood City 41
Saint Petersburg 39
Pretoria 38
Redondo Beach 37
San Diego 37
Shanghai 37
Chicago 36
Hangzhou 35
Turin 35
Frankfurt am Main 34
Haiphong 34
Munich 33
Mülheim 32
Abeokuta 31
Jakarta 31
Changsha 27
São Paulo 27
Tianjin 26
Des Moines 24
London 24
Nanchang 24
Shenyang 24
Verona 24
Bengaluru 23
Falls Church 22
Florence 22
Hebei 22
Phoenix 22
Brussels 21
Nuremberg 20
Biên Hòa 19
Falkenstein 18
Lappeenranta 18
Redmond 17
Toronto 17
Hải Dương 16
Jiaxing 16
Ningbo 16
Zhengzhou 16
Tappahannock 15
Can Tho 13
Johannesburg 13
Olalla 13
Quận Bình Thạnh 13
Yubileyny 13
Amsterdam 12
Atlanta 12
Montreal 12
Brooklyn 11
Chennai 11
Fuzhou 11
Stockholm 11
Totale 10.190
Nome #
A rapid and specific real-time RT-PCR assay to identify Usutu virus in human plasma, serum, and cerebrospinal fluid 279
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 257
Infections in liver and lung transplant recipients: A national prospective cohort 251
New evidence of cutaneous leishmaniasis in north-eastern Italy 247
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 244
Molecular remodeling of potassium channels in fibroblasts from centenarians: a marker of longevity? 239
Persistence of anti-west nile virus-specific antibodies among asymptomatic blood donors in Northeastern Italy. 229
Serological and molecular tools to diagnose visceral leishmaniasis: 2-years' experience of a single center in Northern Italy 228
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 227
Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients 224
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 217
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 213
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 210
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 208
Comparative genomic and phylogenetic analysis of the first usutu virus isolate from a human patient presenting with neurological symptoms. 208
Chikungunya: an emerging and spreading arthropod-borne viral disease. 202
The central region of the msp gene of Treponema denticola has sequence heterogeneity among clinical samples, obtained from patients with periodontitis 202
Detection of Usutu-virus-specific IgG in blood donors from northern Italy 197
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 190
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates 188
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 183
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 183
Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. 181
Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. 181
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 179
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 177
Blood culture systems: rapid detection-how and why? 176
Killing of Treponema denticola by mouse peritoneal macrophages. 174
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections 168
A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy. 168
Comparative Usutu and West Nile virus transmission potential by local Culex pipiens mosquitoes in north-western Europe 168
Evaluation of Phenotypic and Genotypic Approaches for the Detection of Class A and Class B Carbapenemases inEnterobacteriaceae 167
Treponema Denticola alters cell vitality and induces HO1 and HSP70 expression in porcine Aortic Endothelial cells. 166
Whole Genome Sequencing of a Chlamydia trachomatis Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy 165
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF) 164
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia 164
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient 162
Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses. 162
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 162
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing 160
Phylogenetic analysis of West Nile virus isolates, Italy, 2008-2009. 160
Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012. 159
Human infection with highly pathogenic a(H7N7) avian influenza virus, Italy, 2013 159
Imported cases of dengue virus infection: Emilia-Romagna, Italy, 2010. 159
False-positive transcription-mediated amplification assay detection of West Nile virus in blood from a patient with viremia caused by an Usutu virus infection. 156
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 155
Mosquito, bird and human surveillance of west nile and usutu viruses in Emilia-Romagna region (Italy) in 2010. 153
The Gut Microbiota of Critically Ill Patients With COVID-19 153
Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis 152
A novel IncA plasmid carrying blaVIM-1 in a Kluyvera cryocrescens strain 151
Heterogeneity of West Nile virus genotype 1a in Italy, 2011 150
Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy 150
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 150
Seroprevalence of West Nile virus-specific antibodies in a cohort of blood donors in northeastern Italy 147
Development of a broad-range 23S rDNA real-time PCR assay for the detection and quantification of pathogenic bacteria in human whole blood and plasma specimens. 146
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 146
Diagnostic methods for CHIKV based on serological tools 144
Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: Conventional culture vs BioFire FilmArray pneumonia Plus panel 144
The experience of West Nile virus integrated surveillance system in the Emilia-Romagna region: five years of implementation, Italy, 2009 to 2013 143
Detection of specific antibodies against West Nile and Usutu viruses in healthy blood donors in northern Italy, 2010-2011. 142
Complete genome sequence and antimicrobial resistance analysis of ESBL-producing Shigella sonnei carrying small cryptic plasmids isolated in northern Italy. 140
Outbreak of NDM-1-producing Enterobacteriaceae in northern Italy, July to August 2011. 139
Clinical application of a molecular method based on real time RT-PCR for detection od influenza A(H1N1)v 139
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 135
Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia 134
Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient 133
Retrospective screening of solid organ donors in Italy, 2009, reveals unpredicted circulation of West Nile virus. 133
Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae 131
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of KPC-producing Klebsiella pneumoniae 131
Major surface protein complex of Treponema denticola induces the production of tumor necrosis factor alpha, interleukin-1beta, interleukin-6 and matrix metalloproteinase 9by primary human peripheral blood monocytes. 130
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 128
Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC-Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020 127
Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases 126
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients 124
Draft Genome Sequences of Two Multidrug Resistant Klebsiella pneumoniae ST258 Isolates Resistant to Colistin. 124
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring 124
Persistence of anti-chikungunya virus-specific antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy. 123
Rectal screening of carbapenemase-producing Enterobacteriaceae: a proposed workflow 123
Serodiagnosis of visceral leishmaniasis in northeastern italy: Evaluation of seven serological tests 123
Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment 122
West Nile virus circulation in Emilia-Romagna, Italy: the integrated surveillance system 2009. 118
Suboptimal drug exposure leads selection of different subpopulations of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae in a critically ill patient 117
Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021 113
Humans parasitized by the hard tick Ixodes ricinus are seropositive to Midichloria mitochondrii: is Midichloria a novel pathogen, or just a marker of tick bite? 113
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 113
Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March - 30 September 2010. 111
Draft Genome of Klebsiella pneumoniae Sequence Type 512, a Multidrug-Resistant Strain Isolated during a Recent KPC Outbreak in Italy. 109
In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies 108
Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital 106
Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection: due to OXA-181-producing Klebsiella pneumoniae 105
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 105
Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase 104
Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August- September 2009. 104
Phenotypic and genotypic characterization of Klebsiella pneumoniae strains with reduced susceptibiliy to carbapenems 104
Do mosquito-associated bacteria of the genus Asaia circulate in humans? 104
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia 100
Detection of West Nile virus RNA (lineages 1 and 2) in an external quality assessment programme for laboratories screening blood and blood components for West Nile virus by nucleic acid amplification testing. 100
Evaluation of five carbapenemase detection assays for Enterobacteriaceae harbouring bla KPC variants associated with ceftazidime/avibactam resistance 98
Evaluation of synergistic activity of fosfomycin in combination with novel ß-lactams/ß-lactamase inhibitor combinations (βL-βLICs) against KPC-producing Klebsiella pneumoniae clinical isolates 97
Retrospective screening of serum and cerebrospinal fluid samples from patients with acute meningo-encephalitis does not reveal past Japanese encephalitis virus infection, Emilia Romagna, Italy, 2011 94
Totale 15.601
Categoria #
all - tutte 46.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021549 0 0 0 0 0 0 0 0 0 57 55 437
2021/20221.748 147 51 76 208 126 94 48 156 71 179 344 248
2022/20232.007 185 214 102 276 171 128 59 128 344 99 163 138
2023/2024826 50 96 62 88 64 173 47 62 26 73 44 41
2024/20252.638 119 361 232 218 427 153 184 127 41 168 131 477
2025/20265.552 609 622 540 454 661 335 618 212 1.156 345 0 0
Totale 16.552